Jersey Opera House gets third chairperson of 2025
Laura Robertson, a lawyer, has stepped into the position having already served as part of the board of directors.
The decision comes after Cyril Whelan announced on Wednesday he was to resign having only just succeeded another outgoing interim chairperson in April.
Jersey Opera House's Grade II listed building in St Helier reopened after five years in May following a major £13m refurbishment scheme.
More news stories for Jersey
Listen to the latest news for Jersey
Follow BBC Jersey on X and Facebook. Send your story ideas to channel.islands@bbc.co.uk.
Jersey Opera House's interim chair steps down
Opera House reopens for Liberation Day concerts
Jersey Opera House
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Mountain Valley MD Holdings Announces Changes to Board of Directors
TORONTO, July 24, 2025--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce the appointment of David Batchelor to its board of directors. David Batchelor is a seasoned organizational strategist and business transformation expert with more than 25 years of experience advising executive teams and boards on performance improvement, financial discipline, and enterprise value creation. His work spans a wide range of industries—including finance, healthcare, consumer goods, technology, and manufacturing—and includes engagements with global leaders such as Cisco, Coca-Cola, IBM, Merck, Bayer, and Johnson & Johnson. David brings a unique blend of systems thinking, operational insight, and financial acumen to drive results at the intersection of strategy and execution. With a strong foundation in governance and performance science, David is particularly skilled in helping organizations optimize capital allocation, align leadership structures, and implement high-leverage interventions that improve profitability and accountability. His academic background includes a Master's degree in Distributed Learning (Organizational Leadership), undergraduate studies in Management Science, and CMA coursework. As a published author and educator, he has held faculty and program leadership roles at the Schulich Executive Education Centre (York University) and Royal Roads University. David is known for his practical, people-centric approach to driving sustainable business success. "We are very excited to have David Batchelor join our board of directors at this important time in MVMD's development," stated Dennis Hancock, President and CEO of MVMD. "David brings a proven track record in business growth, governance, and financial management that aligns perfectly with our priorities for growth, commercialization, and disciplined capital deployment." The Company also announces the resignations of Kevin Puloski and Nancy Richardson as directors of the Company. Mr. Hancock continued: "As we continue to advance our strategic priorities, including commercialization and capital market initiatives, we're making important enhancements to the composition of our Board. We extend our thanks to the outgoing directors for their contributions and wish them well. The newly appointed director brings relevant perspectives and complementary strengths, reinforcing our commitment to disciplined execution and long-term value creation." ABOUT MOUNTAIN VALLEY MD HOLDINGS Valley MD is building a world-class organization centered around the implementation, licensing and reselling of key technologies and formulations: patented Quicksome™ oral formulation and delivery technologies, patented Quicksol™ solubility formulation technology licensed product reseller of Agrarius™, a novel agricultural plant signaling technology Consistent with its vision towards "More Life", MVMD applies its owned and licensed technologies to its work for advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more. Additionally, MVMD's work with Agrarius is focused on generating a positive impact on crop yields and reducing fertilizer usage. MVMD's patented Quicksome™ technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats. The result is a new generation of product formulations that could be capable of delivering nutraceutical and drug molecules into the body faster, with greater impact, efficiency and accuracy. MVMD's patented Quicksol™ technology covers all highly solubilized macrocyclic lactones that could be effectively applied in multiple viral applications that could positively impact human and animal health globally. MVMD's licensed Agrarius™ agricultural plant signaling technology is designed to be applied to crops to naturally increase yields, reduce fertilizer usage, and increase general resilience to pests and climate change. For more Company information and contact details, visit SOURCE: Mountain Valley MD Holdings Inc. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Company's actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation. Neither the CSE nor OTC has reviewed or approved the contents of this press release. View source version on Contacts For further information:Dennis HancockPresident and Chief Executive OfficerMountain Valley MD Holdings Relations @ 647-725-9755Email: info@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 hours ago
- Yahoo
American Express Elects Randal K. Quarles and Noel Wallace to Board of Directors
NEW YORK, July 23, 2025--(BUSINESS WIRE)--American Express Company (NYSE: AXP) today announced that Randal K. Quarles and Noel Wallace have been elected to its Board of Directors, effective July 23, 2025. With these appointments, the American Express Board increases to 14 members. Mr. Quarles has served as the Executive Chairman and Co-Founder of The Cynosure Group, a diversified investment firm, since 2022. He previously served as Vice Chairman for Supervision of the Board of Governors of the Federal Reserve System from 2017 to 2021, during which time he was also appointed Chair of the Financial Stability Board. "We are honored to welcome Randy, who brings decades of financial services, public service, financial regulation and private equity experience, to our Board," said Stephen J. Squeri, Chairman and Chief Executive Officer at American Express. "As a distinguished leader who helped shape the U.S. financial regulatory framework, as well as the global financial system, he will add invaluable perspectives to American Express." Mr. Wallace has served as the President and Chief Executive Officer of Colgate-Palmolive Company (Colgate-Palmolive), a worldwide consumer products company, since 2019 and Chairman of its Board of Directors since 2020, after being elected to the Board of Directors in 2019. Mr. Squeri continued "Noel has extensive leadership experience driving the growth and transformation of large-scale business operations and global consumer brands. His international operational acumen, and in-depth branding and marketing expertise will be tremendous assets to support our company's long runway for growth." Mr. Quarles will join the Board's Nominating, Governance, and Public Responsibility Committee and Risk Committee. Mr. Wallace will join the Board's Audit and Compliance Committee and Compensation and Benefits Committee. Randal K. Quarles Prior to his appointment to the Board of Governors of the Federal Reserve System, Mr. Quarles was Managing Partner of The Cynosure Group from its founding in 2013 to 2017, and a partner at The Carlyle Group, a global investment firm, from 2007 to 2013. Previously, he served as Under Secretary for Domestic Finance at the U.S. Department of the Treasury from 2005 to 2006, and Assistant Secretary of the Treasury for International Affairs from 2002 to 2005. During this tenure, Mr. Quarles was the Policy Chair of the Committee on Foreign Investment in the U.S. Earlier in his career, he was the U.S. Executive Director of the International Monetary Fund from 2001 to 2002; a Partner at the international law firm of Davis, Polk & Wardwell from 1993 to 2001; and Deputy Assistant Secretary of the Treasury for Financial Institutions and Special Assistant to the Secretary of the Treasury for Banking Legislation from 1991 to 1993. Mr. Quarles currently serves on the Supervisory Board of Patomak Global Partners, LLC, a financial services consulting firm, and on the Boards of Directors of Intermountain Health, the largest hospital system in the Mountain West, and GSS UK Services Limited, a UK company providing compliance technology for financial firms. He received his Bachelor of Arts from Columbia University and his Juris Doctor from Yale University. Noel Wallace Mr. Wallace began his career at Colgate-Palmolive in 1987 and progressed through a series of senior management roles around the world, including President and Chief Operating Officer from 2018 to 2019, responsible for all of the operating units worldwide; Chief Operating Officer, Global Innovation & Growth and Hill's Pet Nutrition from 2016 to 2018; President, Colgate Latin America from 2013 to 2016; President, Colgate North America and Global Sustainability from 2010 to 2013; and other management positions of increasing responsibility at Colgate-Palmolive. Mr. Wallace previously served on the Board of Directors of Kellanova, formerly known as the Kellogg Company, from 2015 to 2018. He has been a member of the Board of Directors of The Consumer Goods Forum since 2019 and the Board of Trustees of New York Presbyterian Hospital since 2021. Mr. Wallace received his Bachelor of Business Administration from Texas A&M University. ABOUT AMERICAN EXPRESSAmerican Express (NYSE: AXP) is a global payments and premium lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services and experiences that enrich lives and build business success. Founded in 1850 and headquartered in New York, American Express' brand is built on trust, security, and service, and a rich history of delivering innovation and Membership value for our customers. With over a hundred million merchant locations across our global network, we seek to provide the world's best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations. For more information about American Express, visit and Source: American Express Company Location: Global View source version on Contacts Media: Amanda Miller, +1.408.219.0563Deniz Yigin, +1.332.999.0836Investors/Analysts: Kartik Ramachandran, +1.212.640.5574Amanda Blumstein, +1.212.640.5574 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 hours ago
- Yahoo
Lincoln Electric Board Declares Dividend
CLEVELAND, July 23, 2025--(BUSINESS WIRE)--Lincoln Electric Holdings, Inc., (Nasdaq: LECO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.75 per common share, payable October 15, 2025, to shareholders of record as of September 30, 2025. Business Lincoln Electric is the world leader in the engineering, design, and manufacturing of advanced arc welding solutions, automated joining, assembly and cutting systems, plasma and oxy-fuel cutting equipment, and has a leading global position in brazing and soldering alloys. Lincoln is recognized as the Welding Expert™ for its leading materials science, software development, automation engineering, and application expertise, which advance customers' fabrication capabilities to help them build a better world. Headquartered in Cleveland, Ohio, Lincoln operates 71 manufacturing and automation system integration locations across 20 countries and maintains a worldwide network of distributors and sales offices serving customers in over 160 countries. For more information about Lincoln Electric and its products and services, visit the Company's website at View source version on Contacts Amanda ButlerVice President, Investor Relations & CommunicationsTel: 216.383.2534Email: Amanda_Butler@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
